Medicure (MCUJF) Common Equity (2009 - 2026)

Medicure's Common Equity history runs 18 years deep, the most recent figure standing at $9.2 million for Q1 2026.

• On a quarterly basis, Common Equity fell 34.15% year-over-year to $9.2 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a 34.15% decrease from a year earlier, with the FY2025 full-year figure at $9.2 million, down 39.12% from the prior year.
• Common Equity held at $9.2 million in Q1 2026 per MCUJF's latest filing, from $9.3 million in the prior quarter.
• Across five years, Common Equity topped out at $16.3 million in Q3 2023 and bottomed at $9.2 million in Q1 2026.
• The 5-year median for Common Equity is $14.6 million (2024), against an average of $14.1 million.
• Across the five-year window, Common Equity rose 18.66% in 2022 and sank 37.76% in 2025, its largest moves.
• Year by year, Common Equity stood at $15.5 million in 2022, then retreated by 5.56% to $14.6 million in 2023, then advanced by 1.78% to $14.9 million in 2024, then sank by 37.76% to $9.3 million in 2025, then slipped by 0.37% to $9.2 million in 2026.
• Per Business Quant, the three latest MCUJF Common Equity figures stand at $9.2 million (Q1 2026), $9.3 million (Q4 2025), and $12.6 million (Q3 2025).